[Early results of left ventricular assist device implantation for the treatment of heart failure].
Zhonghua Yi Xue Za Zhi
; 103(12): 920-923, 2023 Mar 28.
Article
en Zh
| MEDLINE
| ID: mdl-36973220
ABSTRACT
Twenty-four male patients who underwent left ventricular assist device (LVAD) implantation due to advanced heart failure in Union Hospital, Fujian Medical University from June 2019 to June 2022 were retrospectively included. The age of patients was 32-61 (48.4±8.4) years. Everheat-â
, HeartCon and Corheart 6 left ventricular assist systems were used in 10, 6 and 8 cases, respectively. All patients were discharged successfully without mechanical failure, thrombosis or secondary thoracotomy for hemostasis. Early postoperative hemodynamics were significantly improved, left ventricular systolic diameter was reduced, left ventricular ejection fraction was gradually improved, and no hemolysis occurred. The patients were followed up for 3 to 39 (17.9±8.6) months, the cardiac function was restored to grade â
to â
¡, and the 6-minute walking test distance increased significantly. Therefore, satisfactory early results can be achieved with left ventricular assist device implantation for the treatment of heart failure.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Corazón Auxiliar
/
Insuficiencia Cardíaca
Tipo de estudio:
Observational_studies
Límite:
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Año:
2023
Tipo del documento:
Article
País de afiliación:
China